← Back to headlines
Evogene outlines AI-driven strategy and anticipates new collaborations
Evogene, a computational biology company, has detailed its ChemPass AI-driven strategy and expects new collaborations as part of an organizational realignment.
5 Mar, 21:47 — 5 Mar, 21:47
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
[Be The Good] How Rappler app users get to interview experts and newsmakers
13m ago
AudioEye Outlines 30% Adjusted EBITDA Growth for 2026 with New AI-Driven Platform
14m ago
Morgan Stanley's top tech banker: It's 'wartime, not peacetime' for software
23m ago
Trump Administration Classifies Anthropic as 'Risky' Company
37m ago